Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2025 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2025 Earnings Call Transcript August 11, 2025Maravai LifeSciences Holdings, Inc. misses on earnings expectations.
Maravai Lifesciences Holdings Inc. (MRVI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 12 West Capital Management Joel Ramin | 12,521,335 | $30,176,417 | 3.19% | |
| 2. | Braidwell LP Alex Karnal | 8,353,287 | $20,131,422 | 0.69% | |
| 3. | Renaissance Technologies Jim Simons | 4,186,189 | $10,088,715 | +2% | 0.01% |
| 4. | Point72 (DIFC) Ltd Steve Cohen | 3,719,502 | $8,964,000 | +139% | 0.34% |
| 5. | Philosophy Capital Jacob Rubin | 2,593,268 | $6,249,776 | 0.31% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.75 | 17,500 | $100,625.00 | 70,046 | 2024-11-12 | Filing | |
| $5.64 | 175,000 | $987,000.00 | 175,000 | 2024-11-11 | Filing | |
| $26.94 | 35,000 | $942,900.00 | 35,000 | 2020-11-25 | Filing | |
| $27.00 | 20,000 | $540,000.00 | 31,852 | 2020-11-24 | Filing | |
| $27.00 | 18,888 | $509,976.00 | 18,888 | 2020-11-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.03 | 25,000 | $125,750.00 | 167,618 | 2025-01-31 | Filing | |
| $9.82 | 9,940,974 | $97,570,659.81 | 20,150,005 | 2024-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,150,005 | $48,561,512 | 5.18% | |
| 2. | 9,694,094 | $23,362,767 | 0% | |
| 3. | 9,380,547 | $22,607,118 | 0% | |
| 4. | 6,069,301 | $14,627,015 | 0.02% | |
| 5. | 3,750,000 | $9,037,500 | 0.93% |
News See All
Wells Fargo Reiterates a Buy Rating on Maravai LifeSciences Holdings (MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the best biotech penny stocks to buy right now.
14 Best Biotech Penny Stocks to Buy Right Now
He acknowledged that biotech has been a “super tough sector” either way, as there are hundreds of publicly traded stocks that do not add up to anything in aggregate.
Maravai LifeSciences (MRVI) Undergoes Leadership Overhaul Amid Transition
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) is one of the 10 best healthcare penny stocks to buy according to analysts.
10 Best Healthcare Penny Stocks to Buy According to Analysts
According to the Centers for Medicare & Medicaid Services (CMS), the US healthcare sector accounted for approximately 17.6% of GDP in 2023.
Quantoom Biosciences and TriLink BioTechnologies Sign a Supply and License Agreement
Through this agreement, Quantoom will be able to integrate TriLink's CleanCap® mRNA capping technology into its Ntensify® platform, facilitating effective RNA synthesis and wider distribution of vaccines...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2025 Earnings Call Transcript
Operator: Please stand by, we're about to begin. Good afternoon, everyone, and welcome to the Maravai LifeSciences Q1 2025 Results Earnings Call.
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2024 Earnings Call Transcript
Operator: Greetings. Welcome to Maravai LifeSciences Fourth Quarter 2024 Results Earnings Call. At this time, all participants are in a listen-only mode.
Top 10 Stocks to Buy According to 12 West Capital Management
Joel Ramin founded 12 West Capital Management in August 2011, establishing it as a New York-based hedge fund specializing in global investments across equities, equity-related instruments, and credit ...
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds
Shares priced under $5, commonly referred to as penny stocks, are a tempting bet for investors chasing big returns with minimal upfront investment.